ACTIVE SPECIFIC ADJUVANT IMMUNOTHERAPY WITH VACCINIA MELANOMA ONCOLYSATE

被引：7

作者：

SCOGGIN, SD ^{[1
]}

SIVANANDHAM, M ^{[1
]}

SPERRY, RG ^{[1
]}

WALLACK, MK ^{[1
]}

机构：

[1] MT SINAI MED CTR,DEPT SURG,MIAMI BEACH,FL 33140

来源：

ANNALS OF PLASTIC SURGERY | 1992年 / 28卷 / 01期

关键词：

D O I：

10.1097/00000637-199201000-00027

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Vaccinia melanoma oncolysate is an investigative agent for active specific adjuvant immunotherapy. Viral oncolysate work in animals has led to application of this treatment in humans. Success of initial trials in treatment of melanoma has led to a phase III randomized, prospective, double-blind, multi-institutional trial, which is currently under way.

引用

页码：108 / 109

页数：2

共 11 条

[1] VIRAL ONCOLYSIS - INCREASED IMMUNOGENICITY OF HOST CELL ANTIGEN ASSOCIATED WITH INFLUENZA VIRUS [J].

LINDENMANN, J ;

KLEIN, PA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1967, 126 (01) :93-+

[2]

MITCHISO.NA, 1970, TRANSPLANT P, V2, P92

[3]

SHARPLESS GR, 1950, P SOC EXP BIOL MED, V73, P270, DOI 10.3181/00379727-73-17651

[4]

WALLACK MK, 1986, CANCER, V57, P649, DOI 10.1002/1097-0142(19860201)57:3<649::AID-CNCR2820570342>3.0.CO

[5]

2-6

[6]

WALLACK MK, 1977, CANCER, V39, P560, DOI 10.1002/1097-0142(197702)39:2<560::AID-CNCR2820390227>3.0.CO

[7]

2-M

[8]

WALLACK MK, 1987, ARCH SURG-CHICAGO, V122, P1460

[9]

WALLACK MK, 1981, CANCER IMMUNOL IMMUN, V12, P1

[10] SPECIFIC TUMOR-IMMUNITY PRODUCED BY THE INJECTION OF VACCINIA VIRAL ONCOLYSATES [J].

WALLACK, MK .

JOURNAL OF SURGICAL RESEARCH, 1982, 33 (01) :11-16

← 1 2 →